The store will not work correctly when cookies are disabled.
5-(ethoxymethyl)-7-[(4-methyl-1-piperidyl)methyl]quinolin-8-ol
ID: ALA5202771
PubChem CID: 23604740
Max Phase: Preclinical
Molecular Formula: C19H26N2O2
Molecular Weight: 314.43
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOCc1cc(CN2CCC(C)CC2)c(O)c2ncccc12
Standard InChI: InChI=1S/C19H26N2O2/c1-3-23-13-16-11-15(12-21-9-6-14(2)7-10-21)19(22)18-17(16)5-4-8-20-18/h4-5,8,11,14,22H,3,6-7,9-10,12-13H2,1-2H3
Standard InChI Key: GJXBQGZQUCVILH-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-1.7822 -0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0676 0.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3558 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3558 -1.0315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0658 -1.4432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7822 -1.0352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3588 -1.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0734 -1.0315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0658 -2.2685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4978 -1.4477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2155 -1.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2173 -0.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5029 0.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0734 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7880 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5027 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5027 -1.0315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7881 -1.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0676 1.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2173 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7823 1.4433 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7823 2.2685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4968 2.6810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
7 8 1 0
5 9 1 0
6 10 1 0
11 10 2 0
12 11 1 0
13 12 2 0
1 13 1 0
14 8 1 0
15 14 1 0
16 15 1 0
17 16 1 0
18 17 1 0
8 18 1 0
2 19 1 0
16 20 1 0
19 21 1 0
21 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.43 | Molecular Weight (Monoisotopic): 314.1994 | AlogP: 3.71 | #Rotatable Bonds: 5 |
Polar Surface Area: 45.59 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.43 | CX Basic pKa: 10.01 | CX LogP: 1.85 | CX LogD: 1.59 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.91 | Np Likeness Score: -0.84 |
References
1. Pape VFS, Palkó R, Tóth S, Szabó MJ, Sessler J, Dormán G, Enyedy ÉA, Soós T, Szatmári I, Szakács G.. (2022) Structure-Activity Relationships of 8-Hydroxyquinoline-Derived Mannich Bases with Tertiary Amines Targeting Multidrug-Resistant Cancer., 65 (11.0): [PMID:35613553] [10.1021/acs.jmedchem.2c00076] |